Arcutis Biotherapeutics, Inc. · NASDAQ:ARQT
Watanabe Todd sold 4,375 Arcutis Biotherapeutics, Inc. shares (Form 4)
Traded Aug 3, 2026 · Filed Aug 5, 2026
On Aug 3, 2026, Watanabe Todd (Director, See Remarks) sold 4,375 Arcutis Biotherapeutics, Inc. shares at US$26.12 for US$114K under a trading plan, leaving 717,203 shares. Filed Aug 5, 2026 (Form 4).
- Sold
- 4,375 shares
- Price
- US$26.12
- Value
- US$114K
- Holding after
- 717,203 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, See Remarks
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 3, 2026 | Common Stock | Sale | 4,375 | US$26.12 | 717,203 | Direct |
Source
Related
- Arcutis Biotherapeutics, Inc.
- Watanabe Todd
- Arcutis Biotherapeutics, Inc. shareholders
- Form 4 · Watanabe Todd · May 6, 2026
- Form 4 · Welgus Howard G. · Oct 19, 2026
- Schedule 13G/A · BlackRock, Inc. · Oct 5, 2026
- Form 4 · Matsuda Masaru · Sep 18, 2026
- Form 4 · Welgus Howard G. · Sep 17, 2026
- Form 4 · Matsuda Masaru · Sep 10, 2026